August Bioservices Closes $65M Series B

Dec 01, 2022•about 3 years ago

Amount Raised

$65 Million

Round Type

series b

NashvillePharmaceuticalBiotechnology

Investors

Polaris Partners

Description

August Bioservices, LLC (“August Bio”), a pharmaceutical contract development and manufacturing organization (CDMO) providing drug discovery, development and pharmaceutical manufacturing services, today announced that it secured $65 million in Series B funding led by Oak HC/FT, who led the Series A in July 2020. This round includes participation from existing investor, Polaris Partners.

Company Information

Company

August Bioservices

Location

Elm Hill Pike

Nashville, Arkansas, United States

About

August Bioservices is a Contract Development and Manufacturing Organization (CDMO) headquartered in Nashville, Tennessee. August Bio offers a full range of pharmaceutical contract development and manufacturing services to pharmaceutical and biotech clients. We focus on sterile injectables, topicals, highly-complex formulations, poorly soluble & highly viscous compounds, Uncommon container sizes & fill volumes and offer aseptic and non-aseptic terminally sterilized filling of vials (liquid and lyophilized), syringes and flexible IV bags.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends